[ATX] YoY Quarter Result on 31-Mar-2016 [#Q4]

Stock
[ATX] Amplia Therapeutics Limited
Announcement Date
30-Mar-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q4]
Profit Trend
QoQ- -31.52%
YoY- 14.88%
Quarter Report
ATX's Result
ATX's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue -0 -77 616 1,447 -15 0 0 -
PBT -1,152 -1,802 -3,594 -2,808 -3,299 -1,124 0 -
Tax 0 0 0 0 40 22 0 -
NP -1,152 -1,802 -3,594 -2,808 -3,299 -1,124 0 -
Tax Rate - - - - - - - -
Total Cost 1,152 1,725 4,210 4,255 3,284 1,124 0 -
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin 273,022.75 2,337.94 -583.60 -194.09 22,269.14 0.00 0.00 -
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS -0.03 -0.08 -0.16 -0.15 -0.19 -0.09 0.00 -
EPS Diluted -0.03 -0.08 -0.16 -0.15 -0.19 -0.09 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.